{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:04:14Z","timestamp":1781687054750,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"DOI":"10.7759\/cureus.111013","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:47:43Z","timestamp":1781686063000},"source":"Crossref","is-referenced-by-count":0,"title":["Neurofibromatosis Type 1 Presenting With a Mesenteric Plexiform Neurofibroma and Epididymitis"],"prefix":"10.7759","author":[{"given":"Hannah","family":"Crotty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Rodriguez-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams VC","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009, 123:124-33. 10.1542\/peds.2007-3204","journal-title":"Pediatrics"},{"key":"ref2","article-title":"Neurocutaneous syndromes","author":"Sahin M","year":"2025","unstructured":"Sahin M, Ullrich N, Srivastava S, Pinto AL. Neurocutaneous syndromes. Nelson Textbook of Pediatrics. Kliegman RM, St. Geme III JW (ed): Elsevier, Philadelphia, PA; 2025. 22:3652-63."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52902-2.00053-9","article-title":"Neurofibromatosis type 1 (NF1): diagnosis and management","author":"Ferner RE","year":"2013","unstructured":"Ferner RE, Gutmann DH. Neurofibromatosis type 1 (NF1): diagnosis and management. Handbook of Clinical Neurology. Pardue MT (ed): Elsevier, Philadelphia, PA; 2013. 115:939-55. 10.1016\/B978-0-444-52902-2.00053-9"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0272.2007.00823.x","article-title":"Diagnosis and therapy of acute prostatitis, epididymitis and orchitis","volume":"40","author":"Ludwig M","year":"2008","unstructured":"Ludwig M. Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia. 2008, 40:76-80. 10.1111\/j.1439-0272.2007.00823.x","journal-title":"Andrologia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1258\/095646203765371240","article-title":"Epididymo-orchitis and epididymitis: a review of causes and management of unusual forms","volume":"14","author":"Hagley M","year":"2003","unstructured":"Hagley M. Epididymo-orchitis and epididymitis: a review of causes and management of unusual forms. Int J STD AIDS. 2003, 14:372-7. 10.1258\/095646203765371240","journal-title":"Int J STD AIDS"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius E","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, et al.. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021, 23:1506-13. 10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-04022-1","article-title":"Diagnosis and management of precocious sexual maturation: an updated review","volume":"180","author":"Cheuiche AV","year":"2021","unstructured":"Cheuiche AV, da Silveira LG, de Paula LC, Lucena IR, Silveiro SP. Diagnosis and management of precocious sexual maturation: an updated review. Eur J Pediatr. 2021, 180:3073-87. 10.1007\/s00431-021-04022-1","journal-title":"Eur J Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(95)70449-3","article-title":"Precocious puberty in children with neurofibromatosis type 1","volume":"126","author":"Habiby R","year":"1995","unstructured":"Habiby R, Silverman B, Listernick R, Charrow J. Precocious puberty in children with neurofibromatosis type 1. J Pediatr. 1995, 126:364-7. 10.1016\/s0022-3476(95)70449-3","journal-title":"J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000369802","article-title":"Endocrine implications of neurofibromatosis 1 in childhood","volume":"83","author":"Bizzarri C","year":"2015","unstructured":"Bizzarri C, Bottaro G. Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Paediatr. 2015, 83:232-41. 10.1159\/000369802","journal-title":"Horm Res Paediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/AHMT.S303456","article-title":"Natural history and disease burden of neurofibromatosis type 1 with plexiform neurofibromas: a systematic literature review","volume":"12","author":"Copley-Merriman C","year":"2021","unstructured":"Copley-Merriman C, Yang X, Juniper M, Amin S, Yoo HK, Sen SS. Natural history and disease burden of neurofibromatosis type 1 with plexiform neurofibromas: a systematic literature review. Adolesc Health Med Ther. 2021, 12:55-66. 10.2147\/AHMT.S303456","journal-title":"Adolesc Health Med Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0660","article-title":"Health supervision for children with neurofibromatosis type 1","volume":"143","author":"Miller DT","year":"2019","unstructured":"Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR. Health supervision for children with neurofibromatosis type 1. Pediatrics. 2019, 143:e20190660. 10.1542\/peds.2019-0660","journal-title":"Pediatrics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20776","article-title":"How does the Schwann cell lineage form tumors in NF1?","volume":"56","author":"Carroll SL","year":"2008","unstructured":"Carroll SL, Ratner N. How does the Schwann cell lineage form tumors in NF1?. Glia. 2008, 56:1590-605. 10.1002\/glia.20776","journal-title":"Glia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1590\/s1807-59322008000100008","article-title":"Identification of growth hormone receptor in plexiform neurofibromas of patients with neurofibromatosis type 1","volume":"63","author":"Cunha KS","year":"2008","unstructured":"Cunha KS, Barboza EP, Fonseca EC. Identification of growth hormone receptor in plexiform neurofibromas of patients with neurofibromatosis type 1. Clinics (Sao Paulo). 2008, 63:39-42. 10.1590\/s1807-59322008000100008","journal-title":"Clinics (Sao Paulo)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner RE","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N, et al.. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007, 44:81-8. 10.1136\/jmg.2006.045906","journal-title":"J Med Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100223","article-title":"Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review","volume":"6","author":"Solares I","year":"2021","unstructured":"Solares I, Vi\u00f1al D, Morales-Conejo M, Rodriguez-Salas N, Feliu J. Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review. ESMO Open. 2021, 6:100223. 10.1016\/j.esmoop.2021.100223","journal-title":"ESMO Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad086","article-title":"Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1\/2 trial for inoperable plexiform neurofibromas","volume":"25","author":"Gross AM","year":"2023","unstructured":"Gross AM, Dombi E, Wolters PL, et al.. Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1\/2 trial for inoperable plexiform neurofibromas. Neuro Oncol. 2023, 25:1883-94. 10.1093\/neuonc\/noad086","journal-title":"Neuro Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac146","article-title":"Management of neurofibromatosis type 1-associated plexiform neurofibromas","volume":"24","author":"Fisher MJ","year":"2022","unstructured":"Fisher MJ, Blakeley JO, Weiss BD, et al.. Management of neurofibromatosis type 1-associated plexiform neurofibromas. Neuro Oncol. 2022, 24:1827-44. 10.1093\/neuonc\/noac146","journal-title":"Neuro Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492400-neurofibromatosis-type-1-presenting-with-a-mesenteric-plexiform-neurofibroma-and-epididymitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:47:44Z","timestamp":1781686064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492400-neurofibromatosis-type-1-presenting-with-a-mesenteric-plexiform-neurofibroma-and-epididymitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.111013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}